Sapporo Clinical Laboratory Inc.

    Sapporo Clinical Laboratory Inc.

    TTSE:9776
    330,696,128.00
    JPY
    0.00
    (0.00%)
    0.00P/E
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    2025 Y
    TTM
    Revenue per Share
    687,547,043.48
    719,545,521.74
    858,322,950
    876,412,500
    852,759,800
    872,998,050
    853,280,150
    882,954,200
    875,127,200
    1,005,768,157.89
    1,059,352,210.53
    1,035,911,526.32
    1,118,409,555.56
    1,035,911,526.32
    Basic EPS, GAAP
    19,908,956.52
    21,476,217.39
    28,678,850
    29,527,500
    25,693,700
    34,264,400
    26,164,950
    26,410,200
    39,684,400
    54,888,526.32
    29,927,315.79
    20,008,210.53
    25,787,555.56
    20,008,210.53
    Free Cash Flow per Basic Share
    5,972,434.78
    29,642,217.39
    9,748,300
    21,933,000
    5,484,550
    49,709,800
    19,946,100
    -86,418,250
    -115,762,600
    32,908,368.42
    31,812,842.11
    33,153,578.95
    -30,312,333.33
    - -
    Dividend per Share
    1,914,565.22
    1,895,826.09
    2,194,800
    2,089,700
    1,915,800
    1,742,500
    1,908,850
    1,709,650
    1,712,400
    4,137,052.63
    4,055,157.89
    4,027,947.37
    4,257,944.44
    - -
    Book Value per Share
    192,973,130.43
    212,546,086.96
    270,918,150
    298,358,000
    272,970,550
    354,662,750
    378,923,300
    403,621,850
    441,594,650
    515,581,052.63
    541,449,157.89
    557,425,684.21
    609,925,555.56
    557,425,684.21
    Tangible Book Value per Share
    229,153,521.74
    250,743,913.04
    291,959,800
    318,226,550
    344,308,750
    375,662,050
    396,390,500
    420,867,800
    461,511,550
    540,938,526.32
    567,948,789.47
    583,515,421.05
    626,087,500
    583,515,421.05
    Basic Weighted Avg Shares
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Sales/Revenue/Turnover
    15,814
    16,550
    17,166
    17,528
    17,055
    17,460
    17,066
    17,659
    17,503
    19,110
    20,128
    19,682
    20,131
    19,682
    Operating Margin (%)
    9.65
    10.58
    11.03
    8.82
    4.52
    5.82
    4.78
    5.35
    6.53
    8.04
    5.01
    2.72
    3.51
    2.72
    Depreciation Expense
    343
    339
    334
    303
    334
    342
    309
    245
    271
    547
    519
    536
    559
    - -
    Net Income, GAAP
    458
    494
    574
    591
    514
    685
    523
    528
    794
    1,043
    569
    380
    464
    380
    Effective Tax Rate (%)
    37.35
    42.09
    35.97
    37.83
    31.12
    34.88
    36.04
    37.51
    32.51
    30.33
    33.26
    39.3
    34.55
    39.3
    Profit Margin (%)
    2.9
    2.98
    3.34
    3.37
    3.01
    3.92
    3.07
    2.99
    4.53
    5.46
    2.83
    1.93
    2.31
    1.93
    Working Capital
    2,889
    3,401
    3,412
    3,762
    4,123
    4,681
    5,331
    3,136
    2,807
    3,948
    4,054
    4,390
    3,515
    4,390
    LT Debt
    126
    80
    64
    37
    21
    29
    28
    70
    1,946
    2,343
    2,168
    1,938
    1,678
    1,938
    Total Equity
    5,366
    5,825
    5,961
    6,484
    6,984
    7,597
    7,981
    8,463
    9,272
    10,338
    10,881
    11,183
    11,394
    11,183
    Return on Invested Capital (%)
    16.56
    16.36
    19.14
    14.8
    7.64
    8.82
    6.5
    6.98
    7.56
    8.62
    5.06
    2.41
    3.42
    2.41
    Return on Capital (%)
    9.83
    9.77
    10.66
    10.24
    8.92
    10.86
    7.11
    6.71
    8.33
    8.88
    3.92
    3.09
    3.63
    3.09
    Return on Common Equity (%)
    10.82
    10.59
    11.13
    10.37
    8.99
    10.92
    7.13
    6.75
    9.39
    11.2
    5.66
    3.64
    4.3
    3.64

    Capital Structure

    JPY

    •

    in mil. unless spec.
    Sep'24
    Dec'24
    Mar'24
    ST Debt
    259
    261
    261
    LT Borrowings
    1,532
    1,498
    1,465
    LT Finance Leases
    509
    496
    473
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    - -
    - -
    - -
    Market Capitalization
    - -
    - -
    - -

    Working Capital

    JPY

    •

    in mil. unless spec.
    Sep'24
    Dec'24
    Mar'24
    Total Current Assets
    7,708
    7,880
    7,697
    Cash, Cash Equivalents & STI
    4,065
    3,987
    3,976
    Accounts Receivable, Net
    2,968
    2,976
    2,939
    Inventories
    555
    731
    579
    Total Current Liabilities
    3,398
    3,590
    3,307
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    259
    261
    261
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    JPY

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    6.73%
    6.19%
    1.89%
    Free Cash Flow
    -1.56%
    -55.76%
    -186.62%
    Net Income, GAAP
    2.58%
    5.03%
    22.1%
    Sales/Revenue/Turnover
    1.67%
    2.74%
    2.28%
    Total Cash Common Dividend
    10.41%
    25.43%
    0.15%

    Quarterly Revenue

    JPY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    4,923
    4,940
    4,990
    4,830
    19,682
    2025
    - -
    - -
    - -
    - -
    20,131
    2026
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    JPY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    300,578.95
    - -
    - -
    - -
    20,008,210.53
    2025
    - -
    - -
    - -
    - -
    25,787,555.56
    2026
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    JPY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    - -
    - -
    - -
    - -
    4,027,947.37
    2025
    - -
    - -
    - -
    - -
    4,257,944.44
    2026
    - -
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business